Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Innoviva Inc (NASDAQ:INVA)

11.44
Delayed Data
As of 3:59pm ET
 +0.02 / +0.18%
Today’s Change
6.36
Today|||52-Week Range
16.81
+8.54%
Year-to-Date
After GILD Earnings, Which Biomed Stock is Best Right Now?
5:32pm / Zacks.com - Paid Partner Content
Will Stericycle (SRCL) Disappoint this Earnings Season?
8:43am / Zacks.com - Paid Partner Content
Changyou.com (CYOU) Q2 Earnings: Is a Surprise in Store?
11:55am / Zacks.com - Paid Partner Content
Will Ingersoll-Rand (IR) Surpass Q2 Earnings Estimates?
5:17am / Zacks.com - Paid Partner Content
Gilead (GILD) Beats on Q2 Earnings, Cuts 2016 Sales View
10:38am / Zacks.com - Paid Partner Content
Will Synaptics (SYNA) Disappoint Again in Q4 Earnings?
Jul 25 / Zacks.com - Paid Partner Content
Should You Buy Innoviva (INVA) Ahead of Earnings?
9:23am / Zacks.com - Paid Partner Content
Will Netgear's (NTGR) Earnings in Q2 Spring a Surprise?
Jul 25 / Zacks.com - Paid Partner Content
What's in Store for Waste Management (WM) in Q2 Earnings?
8:43am / Zacks.com - Paid Partner Content
Can Anthem (ANTM) Pull a Surprise this Earnings Season?
Jul 25 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close11.42
Today’s open11.37
Day’s range11.37 - 11.66
Volume304,606
Average volume (3 months)685,367
Market cap$1.3B
Dividend yield8.75%
Data as of 3:59pm ET, 07/26/2016

Growth & Valuation

Earnings growth (last year)+89.33%
Earnings growth (this year)+447.50%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+247.57%
P/E ratioNM
Price/Sales17.94
Price/Book--

Competitors

 Today’s
change
Today’s
% change
EBSEmergent BioSolution...+0.20+0.60%
PBYIPuma Biotechnology I...+4.13+9.94%
ACORAcorda Therapeutics ...-0.14-0.54%
SAGESAGE Therapeutics In...+0.62+1.42%
Data as of 4:02pm ET, 07/26/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)$0.11
Annual revenue (last year)$67.8M
Annual profit (last year)-$18.8M
Net profit margin-27.68%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers

Search for Jobs